News
Deep Bio Inc. ranks 1st in the CAMELYON17 Grand Challenge from post submitting i…
February 12, 2019
The Deep Bio research team set the record in the Camelyon Challenge 17’ currently positioning them in first place. The Camelyon17 Grand Challenge is a global competition organized by the Diagnostic Image Analysis Group (DIAG) and the Radboud University Medical Center to evaluate algorithms that perform automated detection of breast cancer metastases in whole-slide images of lymph node sections.
The Deep Bio research team used their own unique artificial intelligence training method to detect metastasis and predict pN-stage from lymph node histological slides. Their proposed method achieved a kappa score of 0.9570, setting them in first place of the challenge.
2019.02.12
DeepBio
Related News & Resources
